Abstract:Trypanosomatids (order Kinetoplastida), including the human pathogens Trypanosoma cruzi (agent of Chagas disease), Trypanosoma brucei, (African sleeping sickness), and Leishmania (leishmaniasis), affect millions of people and animals globally. T. cruzi is considered one of the least studied and most poorly understood tropical disease-causing parasites, in part because of the relative lack of facile genetic engineering tools. This situation has improved recently through the application of clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9) technology, but a number of limitations remain, including the toxicity of continuous Cas9 expression and the long drug marker selection times. In this study, we show that the delivery of ribonucleoprotein (RNP) complexes composed of recombinant Cas9 from Staphylococcus aureus (SaCas9), but not from the more routinely used Streptococcus pyogenes Cas9 (SpCas9), and in vitro-transcribed single guide RNAs (sgRNAs) results in rapid gene edits in T. cruzi and other kinetoplastids at frequencies approaching 100%. The highly efficient genome editing via SaCas9/sgRNA RNPs was obtained for both reporter and endogenous genes and observed in multiple parasite life cycle stages in various strains of T. cruzi, as well as in T. brucei and Leishmania major. RNP complex delivery was also used to successfully tag proteins at endogenous loci and to assess the biological functions of essential genes. Thus, the use of SaCas9 RNP complexes for gene editing in kinetoplastids provides a simple, rapid, and cloning-and selection-free method to assess gene function in these important human pathogens. IMPORTANCE Protozoan parasites remain some of the highest-impact human and animal pathogens, with very limited treatment and prevention options. The development of improved therapeutics and vaccines depends on a better understanding of the unique biology of these organisms, and understanding their biology, in turn, requires the ability to track and manipulate the products of genes. In this work, we describe new methods that are available to essentially any laboratory and applicable to any parasite isolate for easily and rapidly editing the genomes of kinetoplastid parasites. We demonstrate that these methods provide the means to quickly assess function, including that of the products of essential genes and potential targets of drugs, and to tag gene products at their endogenous loci. This is all achieved without gene cloning or drug selection. We expect this advance to enable investigations, especially in Trypanosoma cruzi and Leishmania spp., that have eluded investigators for decades.

A Cas9 Transgenic Plasmodium Yoelii Parasite for Efficient Gene Editing

RISPR / Cas 9 mediated sequential editing of genes critical for ookinete otility in Plasmodium yoelii

CRISPR/Cas9 Mediated Sequential Editing of Genes Critical for Ookinete Motility in Plasmodium Yoelii.

Efficient Editing of Malaria Parasite Genome Using the CRISPR/Cas9 System

The dCas9-based genome editing in Plasmodium yoelii

Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum

Generation and Functional Characterisation of Plasmodium Yoelii Csp Deletion Mutants Using a Microhomology-Based CRISPR/Cas9 Method.

Constitutive expression of Cas9 and rapamycin-inducible Cre recombinase facilitates conditional genome editing in Plasmodium berghei

Optimization of CRISPR/Cas System for Improving Genome Editing Efficiency in Plasmodium falciparum

Epigenetic Editing by CRISPR/dCas9 in Plasmodium Falciparum

Generation of Plasmodium Yoelii Malaria Parasite for Conditional Degradation of Proteins

Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium

Streptococcus pyogenes Cas9 ribonucleoprotein delivery for efficient, rapid and marker‐free gene editing in Trypanosoma and Leishmania

Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system

CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification

Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins

A scalable CRISPR-Cas9 gene editing system facilitates CRISPR screens in the malaria parasite

Lentiviral Transduction-based CRISPR/Cas9 Editing of Schistosoma mansoni Acetylcholinesterase

CRISPR-mediated genome editing of Plasmodium falciparum malaria parasites

CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact

CRISPR/Cas9 gene editing: Applications in Parasitology